Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
- Professor, Vascular & Interventional, Radiology, Boston University Chobanian & Avedisian School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Harvard Medical School, MD
- Brown University, BS
- Published on 8/1/2022
Farber A. Modern Treatment of Asymptomatic Carotid Stenosis-The Importance of Both Medical Therapy and Carotid Endarterectomy. JAMA Surg. 2022 Aug 01; 157(8):653-654. PMID: 35675059.
- Published on 7/7/2022
Levin SR, Farber A, King EG, Giles KA, Eslami MH, Patel VI, Hicks CW, Rybin D, Siracuse JJ. Female Sex is Associated with More Reinterventions after Endovascular and Open Interventions for Intermittent Claudication. Ann Vasc Surg. 2022 Oct; 86:85-93. PMID: 35809741.
- Published on 7/6/2022
Levin SR, King EG, Farber A, Cheng TW, Rybin D, Siracuse JJ. Unplanned Shunting Is Associated with Higher Stroke Risk after Eversion Carotid Endarterectomy. Ann Vasc Surg. 2022 Nov; 87:362-368. PMID: 35803457.
- Published on 6/14/2022
Powell RJ, Choudhry N, Conte M, Cziraky M, Giles K, Hamza T, Menard M, Rosenfeld K, Rowe V, Siracuse JJ, Strong M, Van Over M, Villarreal M, White C, Farber A. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2022 Dec; 76(6):1642-1650. PMID: 35714891.
- Published on 5/23/2022
Cheng TW, Farber A, King EG, Levin SR, Arinze N, Malas MB, Eslami MH, Garg K, Rybin D, Siracuse JJ. Access site complications are uncommon with vascular closure devices or manual compression after lower extremity revascularization. J Vasc Surg. 2022 Sep; 76(3):788-796.e2. PMID: 35618194.
- Published on 5/1/2022
Farber A. Surgery appears to outperform endovascular therapy for popliteal artery aneurysms; however, the real answer as to which treatment strategy works best and for whom remains elusive. J Vasc Surg. 2022 May; 75(5):1718-1719. PMID: 35461678.
- Published on 4/6/2022
Mathlouthi A, Elsayed N, Al-Nouri O, Farber A, Malas MB. Outcomes of Endovascular-First Versus Bypass-First Approach for Patients With Chronic Limb-Threatening Ischemia Using a Medicare-Linked Database. Ann Vasc Surg. 2022 Sep; 85:119-124. PMID: 35398193.
- Published on 1/4/2022
Arinze NV, Yin W, Lotfollahzadeh S, Napoleon MA, Richards S, Walker JA, Belghasem M, Ravid JD, Hassan Kamel M, Whelan SA, Lee N, Siracuse JJ, Anderson S, Farber A, Sherr D, Francis J, Hamburg NM, Rahimi N, Chitalia VC. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. J Clin Invest. 2022 01 04; 132(1). PMID: 34752422.
- Published on 12/24/2021
Levin SR, Farber A, King EG, Beck AW, Osborne NH, DeMartino RR, Cheng TW, Rybin D, Siracuse JJ. Outcomes of axillofemoral bypass for intermittent claudication. J Vasc Surg. 2022 May; 75(5):1687-1694.e4. PMID: 34954271.
- Published on 12/23/2021
Levin SR, Carlson SJ, Farber A, Kalish JA, King EG, Martin MC, McPhee JT, Patel VI, Rybin D, Siracuse JJ. Percutaneous radial artery access for peripheral vascular interventions is a safe alternative for upper extremity access. J Vasc Surg. 2022 Jul; 76(1):174-179.e2. PMID: 34954273.
View 304 more publications: View full profile at BUMC